Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3294844 | Gastroenterology | 2009 | 12 Pages |
Abstract
Down-regulation of osteopontin, probably through blockade of NR4A2 and Wnt signaling, is an important component of the antitumor activity of cyclooxygenase-2 inhibitors. These factors might be developed as therapeutic targets for intestinal cancers.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Rachid Zagani, Nadim Hamzaoui, Wulfran Cacheux, Aurélien de Reyniès, Benoît Terris, Stanislas Chaussade, Béatrice Romagnolo, Christine Perret, Dominique Lamarque,